Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs9600079
rs9600079 		T 0.710 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs10086908
rs10086908
PCAT1 ; LOC105375751
T 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs11055034
rs11055034
APOLD1 ; LOC107984129
C 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs11125927
rs11125927 		G 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs114780236
rs114780236
WDPCP
G 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs16901814
rs16901814
PCAT1 ; LOC105375751
G 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs2659124
rs2659124
LOC105372441
T 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs4554825
rs4554825
LINC00595
C 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs4826594
rs4826594 		A 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs4842687
rs4842687
LOC107984543
A 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs6117562
rs6117562
SLC52A3
A 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs7542260
rs7542260 		T 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs75777376
rs75777376
PCAT1 ; LOC105375751 ; LOC105375753
C 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs8023793
rs8023793
LINC01169
A 0.700 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs3783553
rs3783553
IL1A
0.010 GeneticVariation BEFREE 4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population. 29023981

2018
dbSNP: rs9282858
rs9282858
SRD5A2
0.100 GeneticVariation BEFREE Prostate cancer and BPH were not associated with the alanine-49 to threonine single nucleotide polymorphism and the (TA)n repeat. 16018939

2005
dbSNP: rs780354238
rs780354238
POLB
0.030 GeneticVariation BEFREE Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator. 16313169

2005
dbSNP: rs1056836
rs1056836
CYP1B1
0.100 GeneticVariation BEFREE Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls. 22504876

2012
dbSNP: rs137852593
rs137852593
AR
0.040 GeneticVariation BEFREE R726L androgen receptor mutation is uncommon in prostate cancer families in the united states. 12539229

2003
dbSNP: rs137852593
rs137852593
AR
0.040 GeneticVariation BEFREE R726L substitution in the hormone binding region of androgen receptor was found in 1 prostate cancer family but no previously uncharacterized germline mutations were detected. 14665948

2004
dbSNP: rs12329760
rs12329760
TMPRSS2
0.030 GeneticVariation BEFREE Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study. 15065083

2004
dbSNP: rs486907
rs486907
RNASEL
0.100 GeneticVariation BEFREE Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. 16054567

2005
dbSNP: rs2279343
rs2279343
CYP2B6
0.010 GeneticVariation BEFREE Lys262Arg polymorphism of the CYP2B6 gene may be a genetic marker for evaluating the risk of sporadic prostate cancer in native Japanese men. 19425200

2009
dbSNP: rs1800562
rs1800562
HFE ; LOC108783645
0.020 GeneticVariation BEFREE C282Y/H63D compound heterozygotes were not at increased risk for colorectal cancer (HR = 1.27; 95% CI = 0.80, 2.01), breast cancer (HR = 1.16; 95% CI = 0.74, 1.84), or prostate cancer (HR = 1.08; 95% CI = 0.68, 1.70). 20099304

2010
dbSNP: rs10993994
rs10993994
MSMB
0.800 GeneticVariation BEFREE rs10993994 in MSMB promoter affects serum MSMB expression, contributes to the genetic predisposition to prostate cancer in southern Chinese Han population. 20333697

2010